Page last updated: 2024-11-03

risperidone and Drooling

risperidone has been researched along with Drooling in 7 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"Preschool children tolerated low-dose risperidone well with no serious adverse effects observed over a 6-month treatment period."2.72Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy. ( Belden, A; Heffelfinger, A; Luby, J; Mrakotsky, C; Spitznagel, E; Stalets, MM; Williams, M, 2006)
" Mean CLZ dosage during the combined treatment was 474."2.43Risperidone augmentation of clozapine: a critical review. ( Christodoulou, GN; Ferentinos, PP; Havaki-Kontaxaki, BJ; Kontaxakis, VP; Paplos, KG; Pappa, DA, 2006)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liang, CS1
Liao, WC1
Yang, FW1
Ho, PS1
Usta, MG1
Tufan, AE1
Cüceloğlu, EA1
Freudenreich, O1
Goff, DC1
Kontaxakis, VP1
Ferentinos, PP1
Havaki-Kontaxaki, BJ1
Paplos, KG1
Pappa, DA1
Christodoulou, GN1
Luby, J1
Mrakotsky, C1
Stalets, MM1
Belden, A1
Heffelfinger, A1
Williams, M1
Spitznagel, E1
Panagiotidis, PT1
Fountoulakis, KN1
Siamouli, M1
Magiria, S1
Iacovides, A1
Kaprinis, G1

Reviews

2 reviews available for risperidone and Drooling

ArticleYear
Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations.
    Acta psychiatrica Scandinavica, 2002, Volume: 106, Issue:5

    Topics: Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Delirium; Drug Therapy, Combination; Evid

2002
Risperidone augmentation of clozapine: a critical review.
    European archives of psychiatry and clinical neuroscience, 2006, Volume: 256, Issue:6

    Topics: Antipsychotic Agents; Clozapine; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Dysk

2006

Trials

1 trial available for risperidone and Drooling

ArticleYear
Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.
    Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:5

    Topics: Antipsychotic Agents; Anxiety; Autistic Disorder; Behavior Therapy; Child Behavior Disorders; Child,

2006

Other Studies

4 other studies available for risperidone and Drooling

ArticleYear
Drug-induced sialorrhoea and excessive saliva accumulation.
    Prescrire international, 2009, Volume: 18, Issue:101

    Topics: Antipsychotic Agents; Benzodiazepines; Cholinesterase Inhibitors; Clozapine; Deglutition Disorders;

2009
Risperidone-induced sialorrhea: dose-related?
    Pharmacopsychiatry, 2010, Volume: 43, Issue:7

    Topics: Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Risperidone; Schizophrenia; Sialorrhe

2010
Diphenhydramine use in the treatment of risperidone-induced sialorrhea.
    Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:3

    Topics: Adolescent; Antipsychotic Agents; Diphenhydramine; Dose-Response Relationship, Drug; Follow-Up Studi

2012
Risperidone-induced sialorrhea responsive to biperiden treatment.
    Schizophrenia research, 2007, Volume: 93, Issue:1-3

    Topics: Administration, Oral; Adolescent; Antipsychotic Agents; Biperiden; Dose-Response Relationship, Drug;

2007